newsfilter
← Latest News
GlobeNewswire·

Assembly Biosciences Announces Pricing of $175 Million in Equity Financings

SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. ("Assembly Bio") (NASDAQ:ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases,